ResearchPhase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation
ResearchOutcomes of Terminal Complement Blockade in Adults with High-Risk Transplant-Associated Thrombotic Microangiopathy: A Comparative Analysis
ResearchChimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study
ResearchAn inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma
ResearchAge 60 or older is an independent predictor of outcomes after thiotepa-based autologous transplant in primary CNS lymphoma: a CIBMTR analysis
ResearchFecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study
ResearchSystematic evaluation of donor-KIR/recipient-HLA interactions in HLA-matched hematopoietic cell transplantation for AML
ResearchAtrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile
ResearchThe sum of the parts: what we can and cannot learn from comorbidity scores in allogeneic transplantation
ResearchComorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT study
ResearchA Simplified Comorbidity Index to Predict Nonrelapse Mortality in Allogeneic Hematopoietic Cell Transplantation
ResearchPoint-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphoma
ResearchVitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma